⚠ FDA NOTICE: These products are NOT FDA approved for human use. Sold for research purposes only. Not for human consumption.
🎟 Have a code? Apply for member pricing:

Research Compound Catalog

Browse our planned peptide formulations. None are currently available for purchase.

⚠ Reminder: These products are NOT FDA approved and cannot be purchased at this time. Prices shown are projected retail prices for when approval is obtained.
📉
Tirzepatide
10 mg

Tirzepatide

$120.00

Vial Size: 10 mg

Dual GLP-1 / GIP receptor agonist. Highly effective weight loss compound (15-22% in trials).

SKU: PP-TIR-10 Category:

Description

Tirzepatide – 10 mg

Tirzepatide is a once-weekly dual GIP and GLP-1 receptor agonist. Marketed as Mounjaro and Zepbound. Studies show 15-22% body weight reduction.

Common Applications:

  • Significant weight loss (often 15-22% of body weight)
  • Type 2 diabetes management
  • Improvement in insulin sensitivity
  • Cardiovascular risk reduction in obese patients

Reference Dosing:

Standard titration: 2.5 mg/wk x 4 weeks → 5 mg x 4 weeks → 7.5 mg → 10 mg → 12.5 mg → 15 mg/wk max.

Notes:

GI side effects (nausea, constipation) are common during titration. Slow titration is recommended.

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide”

Your email address will not be published. Required fields are marked *

Important Notice

These products are NOT currently FDA approved.

The peptide compounds described on this site are for informational and research purposes only. They are not intended to diagnose, treat, cure, or prevent any disease.

The information provided is based on current scientific research and literature regarding peptide compounds. These products are presented as a preview of what may become available pending FDA regulatory approval.

Always consult with a qualified healthcare professional before starting any new supplement or wellness program.

Related products